E156 Micro-Paper · Africa Clinical Trials

Linguistic Barrier Mapping

Africa's linguistic landscape — Arabic in the north, French in the west/center, ...

Africa Trials
3,515
US Trials
159,433
Gap Ratio
45x
Nations
54
Africa hosts 23,873 trials across 54 nations with extreme geographic concentration.
Linguistic Barrier Mapping by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Phase Distribution Africa US Europe Phase 1 11 135.2 55.8 Phase 2 20 164.4 83.6 Phase 3 52 767.2 414.4 Phase 4 12 104.5 61.9 767.2 11
Research Profile Volume Growth Phase3 Complete Diversity
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Enrollment Distribution Africa Reference 5000 10000 15000 20000
No data
Linguistic Barrier Mapping Lorenz Curve 0% 0% 25% 25% 50% 50% 75% 75% 100% 100% Gini = 0.711
Enrollment Density Africa Reference 10000 20000 30000 40000
Why It Matters

Africa's linguistic landscape — Arabic in the north, French in the west/center, English in the east/south, Portuguese in the lusophone states — creates invisible barriers to research collaboration and knowledge transfer.

In the spatial mapping of African clinical research, does the pattern of linguistic barrier mapping reveal structural inequity in African research investment? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the mutual information score as the primary estimand using registry metadata for each nation. Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume. Shannon entropy of the trial distribution was 2.46 bits, confirming substantial concentration beyond random variation. These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape. Interpretation is limited by the use of a single registry and the absence of non-English trial databases.
Question

In the spatial mapping of African clinical research, does the pattern of linguistic barrier mapping reveal structural inequity in African research investment?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the mutual information score as the primary estimand using registry metadata for each nation.

Robustness

Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume.

Interpretation

Shannon entropy of the trial distribution was 2.

Boundary

46 bits, confirming substantial concentration beyond random variation.

Extra

These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape.

Extra

Interpretation is limited by the use of a single registry and the absence of non-English trial databases.